Clinical Trial Detail

NCT ID NCT03281954
Title Clinical Trial of Neoadjuvant Chemotherapy With Atezolizumab or Placebo in Patients With Triple-Negative Breast Cancer Followed After Surgery by Atezolizumab or Placebo
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors NSABP Foundation Inc
Indications

triple-receptor negative breast cancer

Therapies

Atezolizumab

Age Groups: adult senior

No variant requirements are available.